Free Trial

Sonova (SONVY) Stock Forecast & Price Target

Sonova logo
$68.78 +0.70 (+1.03%)
(As of 11/20/2024 ET)

Sonova - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
1
Hold
1
Buy
0

Based on 2 Wall Street analysts who have issued ratings for Sonova in the last 12 months, the stock has a consensus rating of "Reduce." Out of the 2 analysts, 1 has given a sell rating, and 1 has given a hold rating for SONVY.

Consensus Price Target

N/A

Get the Latest News and Ratings for SONVY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Sonova and its competitors.

Sign Up

SONVY Analyst Ratings Over Time

TypeCurrent Forecast
11/22/23 to 11/21/24
1 Month Ago
10/23/23 to 10/22/24
3 Months Ago
8/24/23 to 8/23/24
1 Year Ago
11/22/22 to 11/22/23
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
0 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
Sell
1 Sell rating(s)
1 Sell rating(s)
0 Sell rating(s)
3 Sell rating(s)
Consensus Price TargetN/AN/AN/AN/A
Forecasted UpsideN/AN/AN/AN/A
Consensus Rating
Reduce
Reduce
Hold
Strong Sell

SONVY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SONVY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Sonova Stock vs. The Competition

TypeSonovaMedical CompaniesS&P 500
Consensus Rating Score
1.50
2.80
2.50
Consensus RatingReduceModerate BuyModerate Buy
Predicted UpsideN/A26,931.54% Upside9.83% Upside
News Sentiment Rating
Positive News

See Recent SONVY News
Neutral News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
10/22/2024The Goldman Sachs Group
2 of 5 stars
R. Felton
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong Sell
8/13/2024UBS Group
4 of 5 stars
G. Doyle
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold
5/17/2023JPMorgan Chase & Co.
3 of 5 stars
 DowngradeOverweight ➝ Neutral
5/12/2023Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageUnderperform
1/25/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Underperform
12/12/2022Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageSell
11/22/2022Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetCHF 290 ➝ CHF 330

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 07:02 AM ET.


SONVY Forecast - Frequently Asked Questions

2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Sonova in the last twelve months. There is currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" SONVY shares.

According to analysts, Sonova's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.

Over the previous 90 days, Sonova's stock had 1 upgrade by analysts.

Sonova has been rated by research analysts at The Goldman Sachs Group in the past 90 days.

Analysts like Sonova less than other "medical" companies. The consensus rating for Sonova is Reduce while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SONVY compares to other companies.


This page (OTCMKTS:SONVY) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners